4EA3.B | OPRL1

General Structure Information 4ea3 OPRL1 structure of the n/ofq opioid receptor in complex with a peptide mimetic 3.01Å AUTH A.A.THOMPSON,W.LIU,E.CHUN,V.KATRITCH,H.WU,E.VARDY,X.P.HUANG,AUTH 2 C.TRAPELLA,R.GUERRINI,G.CALO,B.L.ROTH,V.CHEREZOV,R.C.STEVENSTITL STRUCTURE OF THE NOCICEPTIN/ORPHANIN FQ RECEPTOR IN COMPLEXTITL 2 WITH A PEPTIDE MIMETIC.REF NATURE V. 485 395 2012REFN ISSN 0028-0836PMID 22596163DOI 10.1038/NATURE11085 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic […]

See Details
3RJM.B | CASP2

General Structure Information 3rjm CASP2 caspase2 in complex with chdi ligand 33c 2.55Å AUTH M.C.MAILLARD,F.A.BROOKFIELD,S.M.COURTNEY,F.M.EUSTACHE,AUTH 2 M.J.GEMKOW,R.K.HANDEL,L.C.JOHNSON,P.D.JOHNSON,M.A.KERRY,AUTH 3 F.KRIEGER,M.MENICONI,I.MUNOZ-SANJUAN,J.J.PALFREY,H.PARK,AUTH 4 S.SCHAERTL,M.G.TAYLOR,D.WEDDELL,C.DOMINGUEZTITL EXPLOITING DIFFERENCES IN CASPASE-2 AND -3 S(2) SUBSITES FORTITL 2 SELECTIVITY: STRUCTURE-BASED DESIGN, SOLID-PHASE SYNTHESISTITL 3 AND IN VITRO ACTIVITY OF NOVEL SUBSTRATE-BASED CASPASE-2TITL 4 INHIBITORS.REF BIOORG.MED.CHEM. V. 19 5833 2011REFN ISSN 0968-0896PMID 21903398DOI […]

See Details
3CKI.B | TIMP3

General Structure Information 3cki TIMP3 crystal structure of the tace-n-timp-3 complex 2.3Å AUTH M.WISNIEWSKA,P.GOETTIG,K.MASKOS,E.BELOUSKI,AUTH 2 D.WINTERS,R.HECHT,R.BLACK,W.BODETITL STRUCTURAL DETERMINANTS OF THE ADAM INHIBITION BYTITL 2 TIMP-3: CRYSTAL STRUCTURE OF THE TACE-N-TIMP-3TITL 3 COMPLEX.REF J.MOL.BIOL. V. 381 1307 2008REFN ISSN 0022-2836PMID 18638486DOI 10.1016/J.JMB.2008.06.088 Variant Set Distributions Mapped Variants

See Details
2W2J.A | CA8

General Structure Information 2w2j CA8 crystal structure of the human carbonic anhydrase related protein viii 1.6Å AUTH S.S.PICAUD,J.R.C.MUNIZ,A.KRAMM,E.S.PILKA,G.KOCHAN,AUTH 2 U.OPPERMANN,W.W.YUETITL CRYSTAL STRUCTURE OF HUMAN CARBONIC ANHYDRASE-TITL 2 RELATED PROTEIN VIII REVEALS THE BASIS FORTITL 3 CATALYTIC SILENCING.REF PROTEINS V. 76 507 2009REFN ISSN 0887-3585PMID 19360879DOI 10.1002/PROT.22411 Variant Set Distributions Ripley’s K Analysis Plots Variant Set […]

See Details
2NO3.A | MAPK8

General Structure Information 2no3 MAPK8 novel 4-anilinopyrimidines as potent jnk1 inhibitors 3.2Å AUTH M.LIU,S.WANG,J.E.CLAMPIT,R.J.GUM,D.L.HAASCH,AUTH 2 C.M.RONDINONE,J.M.TREVILLYAN,C.ABAD-ZAPATERO,AUTH 3 E.H.FRY,H.L.SHAM,G.LIUTITL DISCOVERY OF A NEW CLASS OF 4-ANILINOPYRIMIDINESTITL 2 AS POTENT C-JUN N-TERMINAL KINASE INHIBITORS:TITL 3 SYNTHESIS AND SAR STUDIES.REF BIOORG.MED.CHEM.LETT. V. 17 668 2007REFN ISSN 0960-894XPMID 17107797DOI 10.1016/J.BMCL.2006.10.093 Variant Set Distributions Ripley’s K Analysis Plots Variant Set […]

See Details
2BCD.A | PPP1CC

General Structure Information 2bcd PPP1CC x-ray crystal structure of protein phosphatase-1 with the marine toxin motuporin bound 2.1Å AUTH J.T.MAYNES,H.A.LUU,M.M.CHERNEY,R.J.ANDERSEN,D.WILLIAMS,AUTH 2 C.F.HOLMES,M.N.JAMESTITL CRYSTAL STRUCTURES OF PROTEIN PHOSPHATASE-1 BOUND TOTITL 2 MOTUPORIN AND DIHYDROMICROCYSTIN-LA: ELUCIDATION OF THETITL 3 MECHANISM OF ENZYME INHIBITION BY CYANOBACTERIAL TOXINS.REF J.MOL.BIOL. V. 356 111 2006REFN ISSN 0022-2836PMID 16343532DOI 10.1016/J.JMB.2005.11.019 Variant Set […]

See Details
2ED7.A | DCC

General Structure Information 2ed7 DCC solution structure of the first fibronectin type iii domain of human netrin receptor dcc -1.0Å AUTH N.TOCHIO,S.KOSHIBA,T.TOMIZAWA,T.KIGAWA,S.YOKOYAMATITL SOLUTION STRUCTURE OF THE FIRST FIBRONECTIN TYPETITL 2 III DOMAIN OF HUMAN NETRIN RECEPTOR DCCREF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
2LQB.A | ATP7B

General Structure Information 2lqb ATP7B metal binding repeat 2 of the wilson disease protein (atp7b) -1.0Å AUTH N.V.DOLGOVA,S.NOKHRIN,C.H.YU,G.N.GEORGE,O.Y.DMITRIEVTITL COPPER CHAPERONE ATOX1 INTERACTS WITH THE METAL-BINDINGTITL 2 DOMAIN OF WILSONS DISEASE PROTEIN IN CISPLATINTITL 3 DETOXIFICATION.REF BIOCHEM.J. V. 454 147 2013REFN ISSN 0264-6021PMID 23751120DOI 10.1042/BJ20121656 Variant Set Distributions Mapped Variants

See Details
2EDE.A | DCC

General Structure Information 2ede DCC solution structure of the sixth fibronectin type iii domain of human netrin receptor dcc -1.0Å AUTH N.TOCHIO,S.KOSHIBA,T.TOMIZAWA,M.YONEYAMA,T.KIGAWA,AUTH 2 S.YOKOYAMATITL SOLUTION STRUCTURE OF THE SIXTH FIBRONECTIN TYPETITL 2 III DOMAIN OF HUMAN NETRIN RECEPTOR DCCREF TO BE PUBLISHEDREFN Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis […]

See Details
3OTQ.A | EPHX2

General Structure Information 3otq EPHX2 soluble epoxide hydrolase in complex with pyrazole antagonist 3.0Å AUTH H.Y.LO,C.C.MAN,R.W.FLECK,N.A.FARROW,R.H.INGRAHAM,A.KUKULKA,AUTH 2 J.R.PROUDFOOT,R.BETAGERI,T.KIRRANE,U.PATEL,R.SHARMA,AUTH 3 M.A.HOERMANN,A.KABCENELL,S.D.LOMBAERTTITL SUBSTITUTED PYRAZOLES AS NOVEL SEH ANTAGONIST: INVESTIGATIONTITL 2 OF KEY BINDING INTERACTIONS WITHIN THE CATALYTIC DOMAIN.REF BIOORG.MED.CHEM.LETT. V. 20 6379 2010REFN ISSN 0960-894XPMID 20934334DOI 10.1016/J.BMCL.2010.09.095 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons […]

See Details